December 4, 2017

ER spending increased 85%, driven by price increases for the most severe cases (2009-2015)

Kevin Kennedy; John Hargraves

Medical bills from the Emergency Room (ER) are a mystery to many patients in the US health system. From incredibly high, varying charges to surprise bills resulting from in/out of network confusion, many Americans have no idea what to expect when it comes to the cost of this necessary service. Recently, Vox reporter, Sarah Kliff, has begun collecting ER bills in an attempt to “bring transparency to these extremely common but little understood fees”. To further the discussion, HCCI is releasing its first freely available data download! Using HCCI’s vast commercial claims dataset, we examined the 5, successive Current Procedural Terminology (CPT) codes for an ER visit which are designed to capture the level of severity and complexity of the ER visit. Analyzed collectively, we used these codes to explore how spending, utilization, and prices for ER visits have changed from 2009 through 2015.


Spending per member on all ER visits increased 85% between 2009 and 2015, largely due to the more than 100% growth in spending on high severity cases.  ER spending growth was driven by price increases. High severity visits had the highest prices and the greatest price growth; the price for the most severe ER visit rose over $400, from $498 in 2009 to $900 in 2015. While overall use of the ER remained constant, there was a significant shift in case mix from low to high severity visits – further magnifying the effects of high severity price increases on spending.


The average price of an ER visit increased in every state. Some states saw price increases well over 100%, while price growth was half the national rate in others. The downloadable dataset alongside this post allows for all types of state-level comparisons across years, severities, and measures.

Download the Dataset

The measures reported are based on ER procedure codes (CPT codes 99281-99285) for HCCI’s ESI population. They do not include the costs of other services patients received during their visit to the ER such as the cost of an injected drug. Therefore, these price and spending measures may not capture the entirety of what is typically thought of as an ER visit. Patients may often receive multiple ER CPT codes during the same visit. The yearly proportion of visits with multiple codes remained constant throughout the study period. When aggregated to the visit level, with each visit classified as high, dual, or low severity depending on the code(s) billed, we continued to see an increase in high severity, decrease in low severity, alongside a decline in overall ER visits. Average spending and prices are calculated from the actual amount paid for each claim line containing one of the 5 ER CPT codes. For more information about the HCCI dataset and the methodology of the calculations, see the Methodology page on the HCCI website.

November 29, 2017

Price of insulin prescription doubled between 2012 and 2016

Amanda Frost; John Hargraves

In honor of National Diabetes Month, our inaugural blog post focuses on a topic of particular interest to people with diabetes: the price of insulin. Insulin is the hormone responsible for the body’s ability to use sugar and prevent dangerously high and potentially deadly levels of blood sugar. Diabetics are unable to make enough insulin to support their bodies’ needs, and thus many are dependent on prescription insulin for daily blood sugar maintenance or to control occasional blood sugar spikes  Recent reports by CBS News, Business Insider, Vox, the Washington Post, and others voice concern about increasing insulin prices. Using HCCI’s health care claims data, we found that the average price of an insulin prescription nearly doubled nationally between 2012 and 2016, with a lot of price variation across states.


The prices presented here are the average price of the average insulin prescription for individuals ages 0-64, covered by employer-sponsored insurance (ESI), and having been diagnosed with diabetes (either T1D or T2D). The data set is weighted to be representative of the ESI population at both the state and national levels. Average prices are calculated from the actual amounts paid for insulin prescriptions filled at either in-person or mail-order pharmacies; these may differ from publicly reported wholesale list prices. These allowed amounts do not reflect any discounts, rebates, or coupons, nor would they include insulin bought over-the-counter. The average insulin prescription in our sample averages about a 40-day supply. All metrics represent insurance claims for both brand and generic insulin; however, we found very few claims for generic insulin prescriptions. For more information about the dataset and the price calculation methodology, see the Methodology page on the HCCI website.

November 29, 2017

Welcome to the HCCI blog – Healthy Bytes!

We’ve launched a blog to expand the way in which we share findings and insights based on our data with the wider world. While we remain committed to our signature publications such as our annual Health Care Cost and Utilization Report and our Issue and Data Briefs, sometimes a finding is just too interesting to wait for a more formal publication. We would love feedback from readers on the numbers we are publishing (or not publishing) on the blog. If there’s a particular topic you think HCCI should focus on, please let us know. We can’t commit to following up on every suggestion but we would love to interact more with others who are equally passionate about health care spending and utilization data.

~ Niall Brennan, President